PREDICTIVE VALUE OF COMBINED GENETIC ENZYMATIC AND LIPIDOMIC DATA IN DISEASE RISK FOR LEWY BODY DISEASE
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Oct 5, 2017
filing date -
Apr 6, 2015
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
This present invention relates to genetic mutations that may be used to evaluate the risk of Lewy body disease in a subject. This invention is based, at least in part, on the discovery that genetic mutations in the genes GBA, SMPD1, HEXA and MCOLN1 are associated with Lewy body disease. As such, these mutations may be used in methods of diagnosing and treating Lewy body disease patients.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully